Ferroptosis-centered Drug Response Information
General Information of the Drug (ID: ferrodrug0313)
Name |
Carabrone
|
||||
---|---|---|---|---|---|
Synonyms |
Carabrone; 1748-81-8; Carabron; (3aR,4aS,5S,5aR,6aR)-5a-methyl-3-methylidene-5-(3-oxobutyl)-3a,4,4a,5,6,6a-hexahydrocyclopropa[f][1]benzofuran-2-one; CCRIS 1880; grandicin; 2H-Cyclopropa(f)benzofuran-2-one, octahydro-5a-methyl-3-methylene-5-(3-oxobutyl)-; MEGxp0_001642; CHEMBL3315226; ACon0_000363; DTXSID90938585; HY-N5020; AKOS015998610; NCGC00385841-01; AC-34820; MS-23515; CS-0032087; A881657; 5a-Methyl-3-methylidene-5-(3-oxobutyl)octahydro-2H-cyclopropa[f][1]benzofuran-2-one; (1R,3S,4S,5R,7R)-5-methyl-10-methylidene-4-(3-oxobutyl)-8-oxatricyclo[5.3.0.0?,?]decan-9-one; (3aR,4aS,5S,5aR,6aR)-5a-Methyl-3-methylene-5-(3-oxobutyl)octahydro-2H-cyclopropa[f]benzofuran-2-one; NCGC00385841-01_C15H20O3_2H-Cyclopropa[f]benzofuran-2-one, octahydro-5a-methyl-3-methylene-5-(3-oxobutyl)-, (3aR,4aS,5S,5aR,6aR)-
Click to Show/Hide
|
||||
Structure |
![]() |
||||
Formula |
C15H20O3
|
||||
IUPAC Name |
(3aR,4aS,5S,5aR,6aR)-5a-methyl-3-methylidene-5-(3-oxobutyl)-3a,4,4a,5,6,6a-hexahydrocyclopropa[f][1]benzofuran-2-one
|
||||
Canonical SMILES |
CC(=O)CCC1C2C1(CC3C(C2)C(=C)C(=O)O3)C
|
||||
InChI |
InChI=1S/C15H20O3/c1-8(16)4-5-11-12-6-10-9(2)14(17)18-13(10)7-15(11,12)3/h10-13H,2,4-7H2,1,3H3/t10-,11+,12+,13-,15-/m1/s1
|
||||
InChIKey |
AGIQIKMGJVLKMA-NLRWUALESA-N
|
||||
PubChem CID |
Full List of Ferroptosis Target Related to This Drug
Unspecific Target
In total 1 item(s) under this Target | ||||
Experiment 1 Reporting the Ferroptosis-centered Drug Act on This Target | [1] | |||
Responsed Disease | Pancreatic cancer | ICD-11: 2C10 | ||
Pathway Response | Ferroptosis | hsa04216 | ||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
In Vitro Model | SW1990 cells | Pancreatic adenocarcinoma | Homo sapiens | CVCL_1723 |
CFPAC-1 cells | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_1119 | |
Capan-2 cells | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0026 | |
PANC-1 cells | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0480 | |
Response regulation | Carabrone showed cytotoxicity against SW1990 pancreatic cancer cells through proliferation and migration inhibition mediating via the Hippo signaling pathway and finally induced the cell death through ferroptosis. | |||